Large Israeli study shows Pfizer's vaccine cuts symptomatic COVID-19 by 94 percent
Israel has now fully vaccinated 28 percent of its population against COVID-19 and administered the first dose to 42 percent of its nine million inhabitants, and its data is very promising. Clalit, the largest of Israel's four health-care providers, reported Sunday that the Pfizer-BioNTech vaccine has resulted in a 94 percent drop in symptomatic COVID-19 infections among those who have gotten both doses and a 92 percent decline in severe illness.
Clalit compared 600,000 Israelis who have been fully vaccinated against an equal number who have not, pairing vaccinated people and non-vaccinated people with a similar age and health profile. The majority of people studied were age 16 to 59, but 170,000 of the 600,000 Israelis were 60 or older. "It is now unequivocal that Pfizer's vaccine against the coronavirus is incredibly effective in real life one week after the second dose, just as was found in the clinical study," Ran Balicer, Clalit's chief innovation officer and one of the study's authors, said in a statement Sunday. He said the vaccine is even more effective two weeks after the second shot.
Israel plans to inoculate most of its population by March, and in return for its early access to the Pfizer vaccine, the country agreed to share its data on vaccine safety, effectiveness, and side effects, The Wall Street Journal reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Overall, COVID-19 cases have dropped by 41 percent in Israel while hospitalizations have dropped by a third, public health experts Ezekiel Emanuel, Céline Gounder, Michael Osterholm, Luciana Borio, Atul Gawande, and Rick Bright write in a USA Today op-ed. "All seven COVID-19 vaccines that have completed large efficacy trials" appear "to be 100 percent effective for serious complications" and death, they added, so "our advice is simple: Take whatever vaccine is offered to you. Right now, all of the vaccines are the 'best.'"
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Post Office's Capture software to be reviewed over 'glitches'
Speed Read Solicitor representing accused postmasters says flaws in the IT system follow 'very similar pattern' to Horizon
By Arion McNicoll, The Week UK Published
-
How would we know if World War Three had started?
Today's Big Question With conflicts in Ukraine, Middle East, Africa and Asia-Pacific, the 'spark' that could ignite all-out war 'already exists'
By Harriet Marsden, The Week UK Published
-
Death Cafe: where people talk mortality over tea and cake
Why everyone's talking about The meet-ups are intended to offer a judgement-free and respectful space to discuss the end of life
By Chas Newkey-Burden, The Week UK Published
-
Post Office's Capture software to be reviewed over 'glitches'
Speed Read Solicitor representing accused postmasters says flaws in the IT system follow 'very similar pattern' to Horizon
By Arion McNicoll, The Week UK Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published
-
Visa and Mastercard agree to lower swipe fees
Speed Read The companies will cap the fees they charge businesses when customers use their credit cards
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published